FDA approves new treatment for postpartum depression

The FDA has approved the first drug specifically designed to treat postpartum depression. In the U.S., about one in nine mothers experience depression after having a baby. As Dr. Tara Narula reports, the new drug is providing hope.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news

Related Links:

Conclusions No statistically significant association between bothersome urinary symptoms and the odds of screening positive for increased risk of postpartum depression was found. Future work in this area is needed.
Source: Female Pelvic Medicine and Reconstructive Surgery - Category: OBGYN Tags: Original Articles Source Type: research
In Canada, about 23 per cent of mothers who recently gave birth reported feelings consistent with either postpartum depression or an anxiety disorder.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
This study aimed to systematically review and assess the evidence regarding the association between dieta...
Source: BMC Pregnancy and Childbirth - Category: OBGYN Authors: Tags: Research article Source Type: research
AbstractPurposeOBGYNs help patients plan families, conceive, and deliver children, however the personal reproductive history and goals, infertility experiences, and birth outcomes of OBGYNs are not well studied.  We aim to characterize female OBGYN reproductive experiences with a particular focus on infertility, reproductive life planning (methods of pregnancy prevention, reasons why pregnancy is/was delayed), birth outcomes (mode of delivery, delivery timing), and the postpartum period (breastfeeding, mat ernity leave, postpartum depression).DescriptionAn anonymous email survey was distributed to female members of Ge...
Source: Maternal and Child Health Journal - Category: Health Management Source Type: research
Publication date: July 2019Source: The Lancet Psychiatry, Volume 6, Issue 7Author(s): The Lancet Psychiatry
Source: The Lancet Psychiatry - Category: Psychiatry Source Type: research
Al-Haddad BJS, Jacobsson B, Chabra S, Modzelewska D, Olson EM, Bernier R, et al. Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In Utero. JAMA Psychiatry 2019, in press.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Current Best Evidence Source Type: research
This study aimed to investigate the relationship between breastfeeding and postpartum depression (PPD) and it included 333 Taiwanese pregnant women. Women who had a higher score of Edinburgh Postnatal Depression Scale (EPDS) were significant older (age ≥ 35, p 
Source: Journal of Obstetrics and Gynaecology - Category: OBGYN Tags: J Obstet Gynaecol Source Type: research
Conclusions for PracticeThis research highlights the lack of effectiveness of existing treatment for maternal psychological distress both to benefit child development and to provide long-term symptom remediation for women. Future research could aim to identify more effective treatments for both women and children.
Source: Maternal and Child Health Journal - Category: Health Management Source Type: research
ConclusionsResults support proceeding to a definitive RCT to evaluate tDCS for antenatal depression. The preliminary efficacy estimates immediately post-treatment and in the postpartum, are encouraging with respect to the potential use of tDCS to improve treatment rates in this population. The trial was registered at: clinical trials.gov (NCT02116127).
Source: Brain Stimulation - Category: Neurology Source Type: research
An expert in perinatal psychopharmacology describes how this novel drug works in the management of postpartum depression, and the challenges posed by its safety requirements.Medscape Ob/Gyn
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news
More News: Babies | Depression | Health | Postnatal Depression